Early transplantation benefits older, higher-risk MDS patients in study

12/13/2011 | MDSBeacon.com

Older patients with higher-risk myelodysplastic syndromes who received early stem cell transplantation and reduced-intensity chemotherapy survived longer than those who did not receive transplants, a study found. Researchers also said older patients with lower-risk MDS should not get early stem cell transplantation unless their quality of life is considerably diminished.

View Full Article in:

MDSBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC